Características clínico-epidemiológicas y consideraciones terapéuticas de los hemangiomas congénitos e infantiles de un hospital de tercer nivel durante un periodo de 3 años: estudio comparativo y revisión de la literatura
Resumen: El diagnóstico diferencial clínico entre los hemangiomas congénitos (HC) y los infantiles (HI) es complicado pero esencial para el tratamiento. El marcador inmunohistoquímico GLUT-1 ayuda a distinguirlos, sin embargo, la biopsia no es habitual. Se diseñó un estudio retrospectivo incluyendo...
Main Authors: | F.J. Melgosa Ramos, T. Díaz-Corpas, S. Santos-Alarcón, M. Galarreta Pascual, A. Aguado Vázquez, A. Mateu Puchades |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-07-01
|
Series: | Actas Dermo-Sifiliográficas |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0001731023002958 |
Similar Items
-
[Translated article] Congenital and Infantile Hemangiomas: Epidemiological, Clinical, and Treatment Characteristics Based on 3 Years’ Experience at a Tertiary Care Hospital – A Retrospective Case Comparison and Review of the Literature
by: F.J. Melgosa Ramos, et al.
Published: (2023-07-01) -
Infantile hemangiomas: An update on pathogenesis, associations, and management
by: Karina L Vivar, et al.
Published: (2018-01-01) -
ORAL TOPICAL TIMOLOL MALEAT OR ORAL PROPRANOLOL TREATMENT FOR INFANTILE HEMANGIOMAS: CLINICAL ANALYSIS OF 403 PATIENTS
by: Terzi Özlem, et al.
Published: (2023-09-01) -
Safe and Effective Treatment of Intracranial Infantile Hemangiomas with Beta-Blockers
by: Aoife Naughton, et al.
Published: (2021-07-01) -
Update on Treatment of Infantile Hemangiomas: What’s New in the Last Five Years?
by: Laura Macca, et al.
Published: (2022-05-01)